|
|
|
| Medical therapy for clinical benign prostatic hyperplasia:a1 Antagonists, 5a reductase inhibitors and their combination |
| Cheuk Fan Shum, Weida Lau, Chang Peng Colin Teo
|
| Department of Urology, Khoo Teck Puat Hospital, Singapore |
|
|
|
|
Abstract Medical therapy for clinical benign prostatic hyperplasia (BPH) has advanced significantly in the last 2 decades. Many new α1 antagonists and 5α reductase inhibitors (5ARi) are now commercially available. The practicing urologist must decide on the most appropriate medication for his patients, taking into consideration various factors like efficacy, dosing regime, adverse effects, cost, patient's socioeconomic background, expectations, drug availability and his own clinical experience. The use of combination therapy added further to the complexity in clinical judgment when prescribing. We highlight some of the key points in prescribing α1 antagonists, 5ARi and their combination, based on our viewpoints and experience as urologists in an Asian clinical setting.
|
|
Received: 04 October 2016
Published: 26 August 2017
|
|
Corresponding Authors:
Cheuk Fan Shum,E-mail address:shum.cheuk.fan@alexandrahealth.com.sg.
E-mail: shum.cheuk.fan@alexandrahealth.com.sg
|
|
|
| [1] |
Etheridge Tyler,Damodaran Shivashankar,Schultz Adam,A. Richards Kyle,Gawdzik Joseph,Yang Bing,Cryns Vincent,F. Jarrard David. Combination therapy with androgen deprivation for hormone sensitive prostate cancer: A new frontier[J]. Asian Journal of Urology, 2019, 6(1): 57-64. |
| [2] |
Hung Jung Jae,Park Jinsung,Tae Kim Won,WookKim Hong,JoonKim Hyung,Hong Sungwoo,JoYang Hee,Chung Hong. The association of benign prostatic hyperplasia with lower urinary tract stones in adult men: A retrospective multicenter study[J]. Asian Journal of Urology, 2018, 5(2): 118-121. |
| [3] |
Guat Ng Lay. Botulinum toxin and benign prostatic hyperplasia[J]. Asian Journal of Urology, 2018, 5(1): 33-36. |
| [4] |
S.J.Chung Amanda,H.Woo Henry. Update on minimally invasive surgery and benign prostatic hyperplasia[J]. Asian Journal of Urology, 2018, 5(1): 22-27. |
| [5] |
H.Kim Eric,A.Brockman John,L.Andriole Gerald. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia[J]. Asian Journal of Urology, 2018, 5(1): 28-32. |
| [6] |
Xu Peng,Xu Abai,Chen Binshen,Zheng Shaobo,Xu Yawen,Li Hulin,Shen Haiyan,Liu Chunxiao. Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP?[J]. Asian Journal of Urology, 2018, 5(1): 48-54. |
| [7] |
Xie Liping,Wang Xiao,Chen Hong,Zheng Xiangyi,Liu Ben,Li Shiqi,Mao Yeqing,Mao Qiqi,Wang Song,Li Jiangfeng,Loch Tillmann. Innovative endoscopic enucleations of the prostate-Xie's Prostate Enucleations[J]. Asian Journal of Urology, 2018, 5(1): 12-16. |
| [8] |
Farhad Fakhrudin Vasanwala, Michael Yuet Chen Wong, Henry Sun Sien Ho, Keong Tatt Foo. Benign prostatic hyperplasia and male lower urinary symptoms:A guide for family physicians[J]. Asian Journal of Urology, 2017, 4(3): 181-184. |
| [9] |
Keong Tatt Foo. Pathophysiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 152-157. |
| [10] |
Rikiya Taoka, Yoshiyuki Kakehi. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 158-163. |
| [11] |
Kok Bin Lim. Epidemiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 148-151. |
| [12] |
Kok Kit Ng, Foo Cheong Ng. The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men[J]. Asian Journal of Urology, 2017, 4(3): 191-194. |
| [13] |
Ho-Yin Ngai, Kar-Kei Steffi Yuen, Chi-Man Ng, Cheung-Hing Cheng, Sau-Kwan Peggy Chu. Metabolic syndrome and benign prostatic hyperplasia:An update[J]. Asian Journal of Urology, 2017, 4(3): 164-173. |
| [14] |
James L. Gulley, Ravi A. Madan. Developing immunotherapy strategies in the treatment of prostate cancer[J]. Asian Journal of Urology, 2016, 3(4): 278-285. |
| [15] |
Luke Wang, Paul Davis, Kevin McMillan. A case of giant prostatic hyperplasia[J]. Asian Journal of Urology, 2016, 3(1): 53-55. |
|
|
|
|
